Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-UpAnne Mathieu-Boué, Pierre Demolis et Jean-François BergmannThérapie, 61 4 (2006) 309-312DOI: https://doi.org/10.2515/therapie:2006055